BR102022015847A2 - Uso de peptídeos e formulação - Google Patents

Uso de peptídeos e formulação

Info

Publication number
BR102022015847A2
BR102022015847A2 BR102022015847A BR102022015847A BR102022015847A2 BR 102022015847 A2 BR102022015847 A2 BR 102022015847A2 BR 102022015847 A BR102022015847 A BR 102022015847A BR 102022015847 A BR102022015847 A BR 102022015847A BR 102022015847 A2 BR102022015847 A2 BR 102022015847A2
Authority
BR
Brazil
Prior art keywords
peptides
present
formulation
antinociceptive
biophysics
Prior art date
Application number
BR102022015847A
Other languages
English (en)
Inventor
Ferreira Lima Letícia
Henrique Soller Ramada Marcelo
Silva Nogueira Marcia
Henrique E Silva Cardoso Marlon
Luiz Franco Octavio
Campos Dias Simoni
Geovana Pinheiro Yoshida Yasmin
Original Assignee
Univ Catolica Dom Bosco Ucdb
Uniao Brasileira De Educacao Catolica Ubec
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Catolica Dom Bosco Ucdb, Uniao Brasileira De Educacao Catolica Ubec filed Critical Univ Catolica Dom Bosco Ucdb
Priority to BR102022015847A priority Critical patent/BR102022015847A2/pt
Priority to PCT/BR2023/050254 priority patent/WO2024031163A1/pt
Publication of BR102022015847A2 publication Critical patent/BR102022015847A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

uso de peptídeos e formulação . a presente invenção descreve peptídeos opioides que podem ser utilizadas para o preparo de medicamentos antinociceptivos. especificamente, a presente invenção compreende três peptídeos com surpreendente eficácia antinociceptiva, e que não apresentam nenhum efeito adverso detectável. a presente invenção se situa nos campos da medicina, bioquímica e biofísica.
BR102022015847A 2022-08-10 2022-08-10 Uso de peptídeos e formulação BR102022015847A2 (pt)

Priority Applications (2)

Application Number Priority Date Filing Date Title
BR102022015847A BR102022015847A2 (pt) 2022-08-10 2022-08-10 Uso de peptídeos e formulação
PCT/BR2023/050254 WO2024031163A1 (pt) 2022-08-10 2023-08-09 Uso de peptídeos e formulação

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BR102022015847A BR102022015847A2 (pt) 2022-08-10 2022-08-10 Uso de peptídeos e formulação

Publications (1)

Publication Number Publication Date
BR102022015847A2 true BR102022015847A2 (pt) 2024-02-15

Family

ID=89850026

Family Applications (1)

Application Number Title Priority Date Filing Date
BR102022015847A BR102022015847A2 (pt) 2022-08-10 2022-08-10 Uso de peptídeos e formulação

Country Status (2)

Country Link
BR (1) BR102022015847A2 (pt)
WO (1) WO2024031163A1 (pt)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5885958A (en) * 1997-03-25 1999-03-23 Administrators Of The Tulane Educational Fund Mu-opiate receptor peptides
BR102014020348A2 (pt) * 2014-08-18 2016-08-16 Embrapa Empresa Brasileira De Pesquisa Agropecuária peptídeos opioides
BR102014020352A2 (pt) * 2014-08-18 2016-08-09 Embrapa Empresa Brasileira De Pesquisa Agropecuária peptídeos opioides

Also Published As

Publication number Publication date
WO2024031163A1 (pt) 2024-02-15

Similar Documents

Publication Publication Date Title
PA8537201A1 (es) Agonistas de ppar
BR102022015847A2 (pt) Uso de peptídeos e formulação
PT1423168E (pt) Composicao farmaceutica que compreende gabapentina ou um seu analogo e uma x-aminoamida e a sua utilizacao como analgesico
UY27641A1 (es) Composiciones farmacéuticas de dispersiones amorfas de fármacos y materiales que forman microfases lipófilas
BR112012033295A2 (pt) polipeptídeos curtos e contendo d-aminoácido para conjugados terapêuticos e seu uso
BR112022022456A2 (pt) Proteínas de ligação de repetição de anquirina e seus usos
ES2178048T3 (es) Uso de rifaximina como medicamento para el tratamiento de diarrea por criptosporidiosis.
AR035987A1 (es) Uso de un compuesto inhibidor de la pde 4 para la manufactura de un medicamento y el medicamento para tratar asma inducida por ejercicio
BR0313470A (pt) Combinações terapêuticas de inibidores erbb quinase e terapias antineoplásicas
BR112023006364A2 (pt) Terapia de combinação de imuno-oncologia com conjugados de il-2 e pembrolizumabe
PA8539101A1 (es) Compuestos de ppar
BR112023022875A2 (pt) Uso farmacêutico de composto peptídico cíclico
ES2177783T3 (es) Uso de la gabapentina y sus derivados en el tratamiento de mania y desorden bipolar.
CO2023012342A2 (es) Inhibidores de enzimas
MA30815B1 (fr) Medicament combine
BR112022020136A2 (pt) Formulação de anticorpo
AR032208A1 (es) Composicion farmaceutica para uso topico a base de corticosteroides para el tratamiento de la fimosis
CO2021011057A2 (es) Composición cosmética/dermatológica
CL2022001900A1 (es) Formulaciones de anticuerpos anti-cd38 y usos de las mismas
BR112023010517A2 (pt) 5'-o-fenilacetil uridina e seu uso terapêutico
CL2011000252A1 (es) Uso de estriol para preparar un medicamento util en la prevencion y/o el tratamiento de atrofia urogenital en mujeres.
BRPI0507784A (pt) métodos e composições para a administração de pró-fármacos de inibidores da bomba de prótons
TWD215855S (zh) 劑量輸送裝置(三)
CO2022006316A1 (es) Arco de desinfección portatil
Mion et al. Ketamine for the prevention of posttraumatic stress disorder in burned patients

Legal Events

Date Code Title Description
B03A Publication of a patent application or of a certificate of addition of invention [chapter 3.1 patent gazette]